ClinicalTrials.govpublic full text
A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.
active immunisation for chikungunya virus infection
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 454074
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.